Select Publications
Journal articles
2020, 'Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis', New England Journal of Medicine, 382, pp. 622 - 631, http://dx.doi.org/10.1056/nejmoa1803537
,2020, 'Crystalglobulinemia in Multiple Myeloma: A Rare Case Report of Survival and Renal Recovery', Canadian Journal of Kidney Health and Disease, 7, http://dx.doi.org/10.1177/2054358120922629
,2020, 'Multicentre registry data analysis comparing outcomes of culture-negative peritonitis and different subtypes of culture-positive peritonitis in peritoneal dialysis patients', Peritoneal Dialysis International, 40, pp. 47 - 56, http://dx.doi.org/10.1177/0896860819879891
,2019, 'The effects of canagliflozin on gout in type 2 diabetes: a post-hoc analysis of the CANVAS Program', The Lancet Rheumatology, 1, pp. e220 - e228, http://dx.doi.org/10.1016/S2665-9913(19)30078-5
,2019, 'Benefits and harms of oral anticoagulant therapy in chronic kidney disease', Annals of Internal Medicine, 171, pp. 181 - 189, http://dx.doi.org/10.7326/M19-0087
,2019, '1216-P: The Effects of Canagliflozin on Uric Acid and Gout in Patients with Type 2 Diabetes in the CANVAS Program', Diabetes, 68, http://dx.doi.org/10.2337/db19-1216-p
,2019, 'Differences in peritoneal dialysis technique survival between patients treated with peritoneal dialysis systems from different companies', Nephrology Dialysis Transplantation, 34, pp. 1035 - 1044, http://dx.doi.org/10.1093/ndt/gfy340
,2019, 'Dual inhibition of gastrointestinal phosphate absorption: More questions than answers', Journal of the American Society of Nephrology, 30, pp. 909 - 910, http://dx.doi.org/10.1681/ASN.2019040333
,2019, 'Recent evidence for direct oral anticoagulants in chronic kidney disease', Current Opinion in Nephrology and Hypertension, 28, pp. 251 - 261, http://dx.doi.org/10.1097/MNH.0000000000000493
,2019, 'Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial', PLoS ONE, 14, http://dx.doi.org/10.1371/journal.pone.0213274
,2019, 'THE ASSOCIATION OF FUNCTIONAL STATUS WITH MORTALITY AND DIALYSIS MODALITY CHANGE: RESULTS FROM THE PERITONEAL DIALYSIS OUTCOMES AND PRACTICE PATTERNS STUDY (PDOPPS)', PERITONEAL DIALYSIS INTERNATIONAL, 39, pp. 103 - 111, http://dx.doi.org/10.3747/pdi.2018.00094
,2019, 'Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction on Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study', BMJ Open, 9, pp. e024382, http://dx.doi.org/10.1136/bmjopen-2018-024382
,2019, 'SAT-224 ESTIMATES OF DIETARY PHOSPHATE CONSUMPTION AND COMMON FOOD SOURCES OF PHOSPHATE IN AUSTRALIANS WITH CHRONIC KIDNEY DISEASE', Kidney International Reports, 4, pp. S100 - S100, http://dx.doi.org/10.1016/j.ekir.2019.05.259
,2019, 'SUN-292 BENEFITS AND HARMS OF VITAMIN D COMPOUNDS IN ADULTS WITH CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS', Kidney International Reports, 4, pp. S281 - S281, http://dx.doi.org/10.1016/j.ekir.2019.05.797
,2018, 'Urate-Lowering Therapy for Preventing Kidney Disease Progression: Are We There Yet?', American Journal of Kidney Diseases, 72, pp. 776 - 778, http://dx.doi.org/10.1053/j.ajkd.2018.07.022
,2018, 'Biocompatible dialysis fluids for peritoneal dialysis', Cochrane Database of Systematic Reviews, 2018, http://dx.doi.org/10.1002/14651858.CD007554.pub3
,2018, 'Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease', Cochrane Database of Systematic Reviews, 2018, http://dx.doi.org/10.1002/14651858.CD011798.pub2
,2018, 'Risk Predictors and Causes of Technique Failure Within the First Year of Peritoneal Dialysis: An Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) Study', American Journal of Kidney Diseases, 72, pp. 188 - 197, http://dx.doi.org/10.1053/j.ajkd.2017.10.019
,2018, 'Outcomes of acinetobacter peritonitis in peritoneal dialysis patients: A multicenter registry analysis', Peritoneal Dialysis International, 38, pp. 257 - 265, http://dx.doi.org/10.3747/pdi.2017.00199
,2018, 'Center Effects and Peritoneal Dialysis Peritonitis Outcomes: Analysis of a National Registry', American Journal of Kidney Diseases, 71, pp. 814 - 821, http://dx.doi.org/10.1053/j.ajkd.2017.10.017
,2018, 'FP468RISK PREDICTORS AND CAUSES OF TECHNIQUE FAILURE WITHIN THE FIRST YEAR OF PERITONEAL DIALYSIS', Nephrology Dialysis Transplantation, 33, pp. i194 - i194, http://dx.doi.org/10.1093/ndt/gfy104.fp468
,2018, 'The relationship between body mass index and organism-specific peritonitis', Peritoneal Dialysis International, 38, pp. 206 - 214, http://dx.doi.org/10.3747/pdi.2017.00188
,2018, 'Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)', BMJ Open, 8, pp. e018794, http://dx.doi.org/10.1136/bmjopen-2017-018794
,2017, 'Outcomes of corynebacterium peritonitis: A multicenter registry analysis', Peritoneal Dialysis International, 37, pp. 619 - 626, http://dx.doi.org/10.3747/pdi.2017.00028
,2017, 'Updates on baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study', Nephrology, 22, pp. 823 - 824, http://dx.doi.org/10.1111/nep.12823
,2017, 'Breast Cancer and Transplantation', American Journal of Transplantation, 17, pp. 2243 - 2253, http://dx.doi.org/10.1111/ajt.14368
,2017, 'Representativeness of honeypot trial participants to Australasian PD patients', Peritoneal Dialysis International, 37, pp. 516 - 522, http://dx.doi.org/10.3747/pdi.2016.00065
,2017, 'TEMPORAL TRENDS IN CLINICAL OUTCOMES OF KIDNEY TRANSPLANTATION FROM 1996 TO 2013 IN AUSTRALIA AND NEW ZEALAND', NEPHROLOGY, 22, pp. 91 - 91, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000408833200309&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Multicenter registry analysis of center characteristics associated with technique failure in patients on incident peritoneal dialysis', Clinical Journal of the American Society of Nephrology, 12, pp. 1090 - 1099, http://dx.doi.org/10.2215/CJN.12321216
,2017, 'Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial', Nephrology, 22, pp. 548 - 554, http://dx.doi.org/10.1111/nep.12815
,2017, 'EARLY PERITONITIS AND ITS OUTCOME IN INCIDENT PERITONEAL DIALYSIS PATIENTS', NEPHROLOGY DIALYSIS TRANSPLANTATION, 32, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000469797101230&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'SP427GLUCOSE-LOWERING DRUGS ADDED TO EXISTING THERAPIES AND RISKS OF MORTALITY AND CARDIOVASCULAR DISEASE IN TYPE 2 DIABETES: NETWORK META-ANALYSIS OF RANDOMIZED TRIALS', Nephrology Dialysis Transplantation, 32, pp. iii264 - iii265, http://dx.doi.org/10.1093/ndt/gfx149.sp427
,2017, 'SP493EARLY PERITONITIS AND ITS OUTCOME IN INCIDENT PERITONEAL DIALYSIS PATIENTS', Nephrology Dialysis Transplantation, 32, pp. iii294 - iii294, http://dx.doi.org/10.1093/ndt/gfx151.sp493
,2017, 'Effect of fish oil supplementation and aspirin use on arteriovenous fistula failure in patients requiring hemodialysis: A randomized clinical trial', Nieren- und Hochdruckkrankheiten, 46, pp. 172 - 173
,2017, 'Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients', Cochrane Database of Systematic Reviews, 2017, http://dx.doi.org/10.1002/14651858.CD009966.pub2
,2017, 'Effect of fish oil supplementation and aspirin use on arteriovenous fistula failure in patients requiring hemodialysis a randomized clinical trial', JAMA Internal Medicine, 177, pp. 184 - 193, http://dx.doi.org/10.1001/jamainternmed.2016.8029
,2017, 'Association of socio-economic position with technique failure and mortality in australian non-indigenous peritoneal dialysis patients', Peritoneal Dialysis International, 37, pp. 397 - 406, http://dx.doi.org/10.3747/pdi.2016.00209
,2017, 'Carvedilol and cardiac biomarkers in dialysis patients: Secondary analysis of a randomized controlled trial', Kidney and Blood Pressure Research, 42, pp. 1033 - 1044, http://dx.doi.org/10.1159/000485589
,2017, 'Long-term allograft and patient outcomes of kidney transplant recipients with and without incident cancer - A population cohort study', Oncotarget, 8, pp. 77771 - 77782, http://dx.doi.org/10.18632/oncotarget.20781
,2016, 'Duration of hemodialysis following peritoneal dialysis cessation in Australia and New Zealand: Proposal for a standardized definition of technique failure', Peritoneal Dialysis International, 36, pp. 623 - 630, http://dx.doi.org/10.3747/pdi.2015.00218
,2016, 'Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients', Clinical Journal of the American Society of Nephrology, 11, pp. 1845 - 1855, http://dx.doi.org/10.2215/CJN.00190116
,2016, 'The Validity of Left Ventricular Mass as a Surrogate End Point for All-Cause and Cardiovascular Mortality Outcomes in People With CKD: A Systematic Review and Meta-analysis', American Journal of Kidney Diseases, 68, pp. 554 - 563, http://dx.doi.org/10.1053/j.ajkd.2016.03.418
,2016, 'Center-specific factors associated with peritonitis risk—a multi-center registry analysis', Peritoneal Dialysis International, 36, pp. 509 - 518, http://dx.doi.org/10.3747/pdi.2015.00146
,2016, 'Glomerular filtration rate decline as a surrogate end point in kidney disease progression trials', Nephrology Dialysis Transplantation, 31, pp. 1425 - 1436, http://dx.doi.org/10.1093/ndt/gfv269
,2016, 'Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes a meta-analysis', JAMA - Journal of the American Medical Association, 316, pp. 313 - 324, http://dx.doi.org/10.1001/jama.2016.9400
,2016, 'Appetite predicts intake and nutritional status in patients receiving peritoneal dialysis', Journal of Renal Care, 42, pp. 123 - 131, http://dx.doi.org/10.1111/jorc.12156
,2016, 'The β-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) feasibility study: A randomized controlled trial', American Journal of Kidney Diseases, 67, pp. 902 - 911, http://dx.doi.org/10.1053/j.ajkd.2015.10.029
,2016, 'Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study', Nephrology, 21, pp. 387 - 396, http://dx.doi.org/10.1111/nep.12629
,2016, 'Baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study', Nephrology, 21, pp. 217 - 228, http://dx.doi.org/10.1111/nep.12573
,2016, 'The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial', Redox Report, 21, pp. 14 - 23, http://dx.doi.org/10.1179/1351000215Y.0000000022
,